|Stem Cell Type||Max. Increase over Control||Day at which peak occurred||Increase over control at end of trial period|
|Endothelial Progenitor Cells||100%||14 days||100%|
|CD133+ Stem Cells||90%||7 days||200%|
|CD 34+ Stem Cells||53%||2 days||10%|
|Hematopoietic Colony Forming Stem Cells||45%||2 days||17%|
|1.||100% increase in endothelial progenitor cells (EPC's), peaking at the end of the two week clinical trial period|
|2.||90% increase in CD133+ stem cells, peaking at 7 days, with 20% increase over control at the end of the two week clinical trial period.|
|3.||53% increase in CD34+ stem cells, peaking at 2 days, with 10% increase over control at the end of the two week clinical trial period.|
|4.||40%-50% increase in hematopoietic colony forming stem cells, peaking at 2 days, with 15-20% increase over control at the end of the two week clinical trial period.|
Following a stroke, individuals with a higher content of circulating stem cells recover better than individuals with fewer circulating stem cells.
|Journal of Neurology, 2007|
Smokers have impaired circulating stem cells, which increase with cessation and decrease with resumption of smoking.
|Arteriosclerosis, Thrombosis, and Vascular Biology, 2004|
Circulating stem cells correlate with vascular health and cardiac risk factors.
|New England Journal of Medicine, 2003|
|Injury||Injured tissue mobilizes or "calls in" stem cells.||Circulation, 2001|
|Cardiac Regeneration||Increasing the number of circulating stem cells with G-CSF leads to a therapeutic effect in cardiac regeneration.||American Journal of Cardiology, 2007|
Individuals with Alzheimer's have reduced levels of circulating stem cells and a correlation exists between the decreased number of circulating stem cells and the severity of the disease.
Patients with migraine headaches have decreased circulating stem cells.
Erectile and endothelial function correlate with circulating endothelial progenitor cell levels.
|Journal of Sexual Medicine, 2009|